Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Rotavirus Vaccine Schedules (RotaTeq and Rotarix)
NCT01266850Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2011
- Primary completion
- Oct 2013
- Modality
- Live Attenuated Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of rotavirus vaccine, live, oral, pentavalent, rotavirus vaccine, live, oral in rotavirus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2011; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalentrotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT01266850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266850.